Alarming eosinophils to combat tumors

Ariel Munitz; Simon Patrick Hogan

doi:10.1038/s41590-019-0318-0

Alarming eosinophils to combat tumors

Ariel Munitz, Simon Patrick Hogan

Clinical Microbiology and Immunology

Tel Aviv University

Research output: Contribution to journal › Comment/debate

Abstract

Combined immunotherapy using checkpoint blockade (anti-CTLA4 and anti-PD-1) and the DPP4 inhibitor sitagliptin reveals the existence of a T cell– and eosinophil-targeted immunotherapy approach for solid tumors.

Original language	English
Pages (from-to)	250-252
Number of pages	3
Journal	Nature Immunology
Volume	20
Issue number	3
DOIs	https://doi.org/10.1038/s41590-019-0318-0
State	Published - 1 Mar 2019

All Science Journal Classification (ASJC) codes

Immunology and Allergy
Immunology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41590-019-0318-0

Cite this

@article{e49bd6d111534f5f8a16fea9a300427f,

title = "Alarming eosinophils to combat tumors",

abstract = "Combined immunotherapy using checkpoint blockade (anti-CTLA4 and anti-PD-1) and the DPP4 inhibitor sitagliptin reveals the existence of a T cell– and eosinophil-targeted immunotherapy approach for solid tumors.",

author = "Ariel Munitz and Hogan, \{Simon Patrick\}",

note = "Publisher Copyright: {\textcopyright} 2019, Springer Nature America, Inc.",

year = "2019",

month = mar,

day = "1",

doi = "10.1038/s41590-019-0318-0",

language = "الإنجليزيّة",

volume = "20",

pages = "250--252",

journal = "Nature Immunology",

issn = "1529-2908",

publisher = "Nature Research",

number = "3",

}

TY - JOUR

T1 - Alarming eosinophils to combat tumors

AU - Munitz, Ariel

AU - Hogan, Simon Patrick

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Combined immunotherapy using checkpoint blockade (anti-CTLA4 and anti-PD-1) and the DPP4 inhibitor sitagliptin reveals the existence of a T cell– and eosinophil-targeted immunotherapy approach for solid tumors.

AB - Combined immunotherapy using checkpoint blockade (anti-CTLA4 and anti-PD-1) and the DPP4 inhibitor sitagliptin reveals the existence of a T cell– and eosinophil-targeted immunotherapy approach for solid tumors.

UR - http://www.scopus.com/inward/record.url?scp=85061846394&partnerID=8YFLogxK

U2 - 10.1038/s41590-019-0318-0

DO - 10.1038/s41590-019-0318-0

M3 - تعليقَ / نقاش

C2 - 30778244

SN - 1529-2908

VL - 20

SP - 250

EP - 252

JO - Nature Immunology

JF - Nature Immunology

IS - 3

ER -

Alarming eosinophils to combat tumors

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this